04:20:00 EDT Fri 04 Jul 2025
Enter Symbol
or Name
USA
CA



Lumiera investor Maison Bleue acquires 22.5 M shares

2025-02-18 17:15 ET - News Release

An anonymous representative of Fiducie de la Maison Bleue reports

ACQUISITION OF SECURITIES OF LUMIERA HEALTH INC.

On Feb. 12, 2025, Fiducie de la Maison Bleue (the acquiror) acquired ownership of 22.5 million common shares of Lumiera Health Inc., pursuant to a debt settlement transaction. The equivalent total consideration for the debt settlement was $225,000, settled through the issuance of 22.5 million shares at a price of one cent per share.

Prior to the acquisition of shares pursuant to the debt settlement, the acquiror held 15,512,821 shares of the issuer, representing approximately 6.63 per cent of the company's issued and outstanding shares.

Immediately after the completion of the debt settlement, the acquiror now owns a total of 38,012,821 shares and nil convertible securities of the issuer and the acquiror's non-diluted shareholdings represent approximately 13.95 per cent of the company's issued and outstanding shares.

As a result of the debt conversion, Robert Brouillette, through himself, the acquiror, 9482-9256 Quebec Inc. and Telebrome Inc., now owns and controls an aggregate of 58,989,858 shares, representing approximately 21.65 per cent of the issued and outstanding common shares of the company. Mr. Brouillette does not, directly or indirectly, hold any convertible securities of the issuer.

The acquiror entered into the transaction for investment purposes. The acquiror and/or Mr. Brouillette may directly or indirectly increase or reduce its/his investment in the issuer according to market conditions or other relevant factors.

The acquiror is a trust formed pursuant to the laws of Quebec. Its principal business is consulting and investment holdings and its head office is located at 1050 Cote du Beaver Hall, Suite 1540, Montreal, Que., H2Z 0A5.

To obtain a copy of the early warning report filed by the acquiror, please contact the acquiror at 514-570-7343 or refer to the company's SEDAR+ profile.

© 2025 Canjex Publishing Ltd. All rights reserved.